Search results
Aug 27, 2021 · Stéphane Bancel: At Moderna, our mission is to deliver on the promise of mRNA science to create a new generation of transformative medicines for patients. Since mRNA is an information-based platform, it works similar to a computer’s operating system, letting researchers insert new genetic code from a virus—like adding an app—to create a ...
Sep 24, 2020 · The biotech firm was planning to expand the newly opened facility to accommodate its vaccine development work, and CEO Stéphane Bancel (MBA 2000, AMP 170) welcomed input on the design from the government’s infectious disease experts. For two years, Moderna had been working closely with the NIH to create a vaccine for Middle East respiratory ...
Jun 7, 2021 · In this episode, we talk to Stéphane Bancel, CEO of Moderna, a biotech company that developed one of the three emergency-approved COVID-19 vaccines in the United States. The Moderna vaccine is unique in that it uses a new technology that has been decades in the making called messenger RNA, or mRNA.
Jan 31, 2014 · Body, Heal Thyself. Stéphane Bancel has taken Moderna Therapeutics from a one-man shop to a company that's poised to revolutionize the biotech world.
Stéphane Bancel, Albert Bourla, and Alex Gorsky are three visionaries whose foresight, energy, and leadership made it possible for COVID-19 vaccines to reach the market on an unprecedented timescale, saving millions of lives. Vaccines are undoubtedly one of the greatest achievements in science history. From polio to measles to meningitis ...
2011–. Spouse. Brenda Bancel. Children. 2. Stéphane Bancel (born 20 July 1972) [1] is a French business executive. He is the chief executive officer (CEO) of the American pharmaceutical and biotechnology company Moderna, known for its COVID-19 vaccine. Before joining Moderna, Bancel was the CEO of French diagnostics company BioMérieux.
Many in the scientific community view the move by Moderna as a betrayal. Today at RE:WIRED, our own senior writer Maryn McKenna sat down with Moderna’s CEO, Stéphane Bancel, along with Nahid Bhadelia, an internationally regarded infectious-disease physician.
